ArticleFrontiers in pharmacology2022

Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure.

Yingdong Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.